LIGAND PHARMACEUTICALS INC - NOTE 0.750% 8/1

Q3 2015 13F Holders as of 9/30/2015

Type / Class
Debt / NOTE 0.750% 8/1
Number of holders
26
Total Principal
244M
Shares change
+219M
Total reported value, excl. options
$317M
Value change
+$284M
Put/Call ratio
0
Number of buys
24
Number of sells
0
Price
$1.30
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.